The International Society of Amyloidosis (ISA) will be hosting a meeting in Athens from 25 to 26 September 2023 (at the Athenaeum Intercontinental) that will bring together basic scientists and clinical experts from Europe, the United States, South America, Asia, and Australia. This two-day conference will define major unresolved questions in the field of amyloidosis (diagnosis and treatment) and develop ideas and networks to answer them, as well as guidelines for laboratory and clinical research and strategies for integrating basic and clinical research with applied clinical practice. Discussions during the two-day conference will revolve around three main topics: precursor toxicity, the interplay between the structure and biology of fibrils, and mouse and other models for amyloidosis, and will cover primary systemic (AL) amyloidosis, transthyretin amyloidosis (ATTR), and other—rarer—forms of the disease (AA amyloidosis, AFib amyloidosis, ApoAI amyloidosis, ALECT amyloidosis, etc.).
The meeting will be under the auspices of the National and Kapodistrian University of Athens (NKUA), the Department of Therapeutics of the NKUA’s School of Medicine (Alexandra General Hospital, Director of the Department: Professor M.-A. Dimopoulos), and the Unit for the Diagnosis and Treatment of Amyloidosis of the above Department. Participating from Greece will be Professor E. Kastritis, Scientist Responsible of the Unit for the Diagnosis and Treatment of Amyloidosis and Secretary of the International Society of Amyloidosis, two NKUA faculty members specializing in the research for the disease, namely Mr K. Stamatelopoulos (Professor of Cardiology at the Department of Therapeutics) and Ms V. Iconomidou (Associate Professor of Biophysics – Molecular Biophysics at the Department of Biology of NKUA), and two postdoctoral researchers at NKUA, namely Drs P.-E. Nikolaou and J. Courraud.
The relevant link to the ISA website is: https://www.isaamyloidosis.org/2023-scientific-workshop
The session has ended for security reasons.